The landscape of diabetes care is advancing with the introduction of GLP-1 patches . These innovative devices offer a potentially less invasive alternative to shots for individuals managing type 2 diabetes . They deliver a GLP-1 agonist directly through the epidermis, avoiding the need for daily injections and possibly enhancing stickiness to th… Read More